Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 3 study of S06911 for osteoporosis with vitamin D deficiency
2009-014270-18Phase 3Completed
- Sponsor
- Servier
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of strontium ranelate + cholecalciferol in osteoporosis, sponsored by Servier. Primary endpoint: Vitamin D3 level. Started Nov 2009; status: completed.
02
Drugs
strontium ranelate + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2009-014270-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014270-18.